OBIO – orchestra biomed holdings, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Orchestra BioMed (OBIO) was downgraded by Weiss Ratings from "sell (d-)" to "sell (e+)".
Orchestra BioMed (OBIO) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Orchestra BioMed (OBIO) was upgraded by Wall Street Zen from "strong
Orchestra BioMed (OBIO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $20.00 price target on the stock.
Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Sherman Darren
Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Aiello Joshua
Form 4 Orchestra BioMed Holding For: Mar 25 Filed by: Hochman David P
Form 4 Orchestra BioMed Holding For: Mar 13 Filed by: Hochman David P
Form 10-K Orchestra BioMed Holding For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.